Skip to main content

Table 3 Top 20 drugs and corresponding BRC-MoA for reverse effect prediction for E2

From: BRCA-Monet: a breast cancer specific drug treatment mode-of-action network for treatment effective prediction using large scale microarray database

Rank

Drug

Mean Expression

MoA

1

monastrol

-3.54584

BRCA_MoA80

2

fulvestrant

-1.64228

BRCA_MoA80

3

raloxifene

-1.08114

BRCA_MoA80

4

bacampicillin

-0.39068

BRCA_MoA86

5

cyproterone

-0.95575

BRCA_MoA52

6

nabumetone

-0.32439

BRCA_MoA52

7

proguanil

-0.32213

BRCA_MoA102

8

deferoxamine

-2.16577

BRCA_MoA50

9

cobalt chloride

-0.25959

BRCA_MoA50

10

wortmannin

-0.60183

BRCA_MoA32

11

LY-294002

-0.5634

BRCA_MoA32

12

sirolimus

-0.2227

BRCA_MoA32

13

metampicillin

-0.65666

BRCA_MoA10

14

cefadroxil

-0.25222

BRCA_MoA10

15

methocarbamol

-0.19939

BRCA_MoA10

16

N-acetylmuramic acid

-0.44691

BRCA_MoA33

17

dobutamine

-0.3141

BRCA_MoA33

18

iohexol

-0.15247

BRCA_MoA33

19

adrenosterone

-0.94798

BRCA_MoA58

20

butamben

-0.41198

BRCA_MoA58